<DOC>
	<DOCNO>NCT00003085</DOCNO>
	<brief_summary>RATIONALE : New diagnostic procedure , laparoscopic ultrasound , may improve ability detect pancreatic cancer determine extent disease . PURPOSE : Phase II trial study effectiveness laparoscopic ultrasound diagnose patient stage I stage II pancreatic cancer .</brief_summary>
	<brief_title>Laparoscopic Ultrasound Diagnosing Patients With Pancreatic Cancer</brief_title>
	<detailed_description>OBJECTIVES : I . Determine whether comprehensive laparoscopic examination abdomen laparoscopic ultrasonography improves stag pancreatic cancer respect ( ) well assessment ( compare CT ) extent localize extra pancreatic disease , ( b ) vascular invasion , ( c ) regional lymph node involvement , ( ) metastatic deposit liver parenchyma . II . Assess whether one new minimally invasive image technique , laparoscopic ultrasonography , predict vascular invasion pancreatic cancer . III . Develop optimal cost effective strategy assess resectability pancreatic cancer . OUTLINE : Patients undergo routine clinical staging ( CT scan , angiogram , etc . ) classify potentially resectable undergo laparoscopy laparoscopic ultrasound ( L+LUS ) . At end L+LUS , base new finding patient reclassify either potentially resectable potentially unresectable . All patient undergo definitive staging : metastasis liver pathologically confirm biopsy time laparoscopy classify unresectable undergo laparotomy ; others undergo laparotomy classified resectable unresectable . If 8 patient misclassified time L+LUS , study terminate . PROJECTED ACCRUAL : There 50 patient accrue study 25 patient stage . In order accrue 50 patient , approximately 70 patient undergo initial routine clinical staging ( CT scan , angiogram , etc . ) .</detailed_description>
	<mesh_term>Pancreatic Neoplasms</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histological radiological evidence stage I II pancreatic cancer No evidence metastatic disease CT scan PATIENT CHARACTERISTICS : Age : Over 18 Performance status : ECOG 02 Life expectancy : Not specify Hematopoietic : Not specify Hepatic : Not specify Renal : Not specify Cardiovascular : No prohibitive anesthetic risk due cardiac disease Pulmonary : No prohibitive anesthetic risk due respiratory disease PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : Not specify Endocrine therapy : Not specify Radiotherapy : Not specify Surgery : No adhesion previous surgery preclude laparoscopy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2014</verification_date>
	<keyword>stage I pancreatic cancer</keyword>
	<keyword>stage II pancreatic cancer</keyword>
</DOC>